Profil
Christina Cameron is currently Director-Investor Relations at Medicago, Inc., Vice President-Investor Relations at Antibe Therapeutics, Inc., and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
from 2019 to present.
Formerly, Ms. Cameron was an Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026.
Education includes an undergraduate degree from Wilfrid Laurier University.
Aktive Positionen von Christina Cameron
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Kontakt | - |
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Kontakt | 01.02.2019 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Christina Cameron
| Unternehmen | Position | Ende |
|---|
Ausbildung von Christina Cameron
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















